Avidity Partners Management LP Vera Therapeutics, Inc. Transaction History
Avidity Partners Management LP
- $885 Million
- Q4 2024
A detailed history of Avidity Partners Management LP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 100,000 shares of VERA stock, worth $2.75 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
100,000Holding current value
$2.75 Million% of portfolio
0.48%Shares
2 transactions
Others Institutions Holding VERA
# of Institutions
193Shares Held
63.8MCall Options Held
78.4KPut Options Held
89.8K-
Avoro Capital Advisors LLC New York, NY5.61MShares$154 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$120 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$91.7 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$81.3 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$81 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $743M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...